ANTI-TUMOUR IMMUNE RESPONSES TO MODIFIED SELF-EPITOPES

• 1. 一种可激活患者的抗肿瘤免疫反应的人肿瘤抗原及其应用 [P] . 中国专利： CN113185597A . 2021-07-30
• 2. 一种增强抗肿瘤免疫反应的组合物及应用 [P] . 中国专利： CN111330007A . 2020-06-26
• 3. ANTI-TUMOUR IMMUNE RESPONSES TO MODIFIED SELF-EPITOPES [P] . 欧洲知识产权局专利： EP3325501B1 . 2020-09-09

  机译： 修改后的自恋者的抗肿瘤免疫反应

• 4. Anti-tumour immune responses to modified self-epitopes [P] . AU2016295337B2 . 2020-07-09

  机译： 对修饰的自身表位的抗肿瘤免疫反应

• 5. Anti-tumour immune responses to modified self-epitopes [P] . 美国专利： US10695438B2 . 2020.06.30

• 1. DYNAMICS ANALYSIS OF A DELAYED HIV INFECTION MODEL WITH CTL IMMUNE RESPONSE AND ANTIBODY IMMUNE RESPONSE [J] . Junxian YANG, Leihong WANG 数学物理学报（英文版） . 2021,第003期
• 2. Anti-tumour immune response in GL261 glioblastoma generated by Temozolomide Immune-Enhancing Metronomic Schedule monitored with MRSI-based nosological images [J] . Wu Shuang, Calero-Perez Pilar, Villamanan Lucia, NMR in biomedicine . 2020,第4期
• 3. 1048 Requirement of fully activated dendritic cells for elicitation of potent anti-tumour immune responses in cancer patients with impaired immunity [J] . K.Kontani, S.Hashimoto, C.Murazawa, European Journal of Cancer Supplements . 2009,第2期
• 4. Modified peptides in anti-cancer vaccines: Are we eventually improving anti-tumour immunity? [J] . IeroM., FilipazziP., CastelliC., Cancer immunology, immunotherapy : . 2009,第7期
• 5. CANscript Is an Ex Vivo Human Tumor Culture Platform Capable of Accurately Capturing Response to Immune Modifying Agents [C] . Mark J. Paris, Saravanan Thyiagarajan, Biswanath Majumder, Protein Engineering Summit. . 2018
• 6. Modifying immune responses via targeted delivery to dendritic cells [D] . Katakowski, Joseph. 2015
• 7. Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response [O] . Thomas H. P. M. Habets, Tammy Oth, Ans W. Houben, -1
• 8. Induction of anti-tumour immunity by suicide-gene-modified HPV-16-transformed hamster cells [O] . V. Vonka, E. Sobotková, E. Ham, 1998

• 1. MontanidesupTM/supGel01 ST Adjuvant Enhances PRRS Modified Live Vaccine Efficacy by Regulating Porcine Humoral and Cellular Immune Responses [J] . Xiangdong Li ,Amy Galliher-Beckley ,Jerome C. Nietfeld . 疫苗（英文） . 2013,第1期
• 2. Perioperative Clinical Interventions That Modify the Immune Response in Cancer Patients [J] . María F. Ramírez ,Johannes M. Huitink ,Juan P. Cata . 麻醉学期刊（英文） . 2013,第3期
• 3. Effects of dendritic cells transfected with full length wild-type p53 and modified by bile duct cancer lysates on immune response [J] . . 国际肝胆胰疾病杂志：英文版 . 2005,第1期
• 4. Effects of Dendritic Cells Transfected with Full Length Wild Type P53 and Modified by Gastric Cancer Lysate on Immune Response [J] . 孙华文 ,唐启彬 ,陈勇军 . 华中科技大学学报（医学）（英德文版） . 2004,第005期
• 5. 血根碱对小鼠抗肿瘤免疫反应的加强作用 [C] . Shen Yanan ,申亚南 ,周菊华 . 世界中联肿瘤经方治疗研究专业委员会第三届学术年会暨国家癌症中心首届中西医肿瘤国际论坛 . 2017
• 6. 蜂毒脂质纳米颗粒诱导的抗肿瘤免疫反应及其机制研究 [A] . 余祥 . 2019